|
SG10201906382QA
(en)
|
2013-05-01 |
2019-08-27 |
Ionis Pharmaceuticals Inc |
Compositions and methods for modulating hbv and ttr expression
|
|
SG10201809953QA
(en)
*
|
2014-05-01 |
2018-12-28 |
Ionis Pharmaceuticals Inc |
Compositions and methods for modulating complement factor b expression
|
|
US10570169B2
(en)
|
2014-05-22 |
2020-02-25 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
US20170145424A1
(en)
*
|
2014-06-06 |
2017-05-25 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
JP7105065B2
(ja)
|
2014-12-15 |
2022-07-22 |
ダイセルナ ファーマシューティカルズ， インコーポレイテッド |
リガンド修飾二本鎖核酸
|
|
US11298427B2
(en)
|
2015-05-29 |
2022-04-12 |
Ascendis Pharma A/S |
Prodrugs comprising a pyroglutamate linker
|
|
JPWO2017010575A1
(ja)
*
|
2015-07-16 |
2018-04-26 |
協和発酵キリン株式会社 |
β２ＧＰＩ遺伝子発現抑制核酸複合体
|
|
CN105524124B
(zh)
*
|
2015-12-31 |
2018-10-30 |
天津英吉诺科技有限公司 |
一种n-乙酰氨基半乳糖的绿色合成方法
|
|
AU2017213404A1
(en)
|
2016-01-29 |
2018-09-20 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
TWI842117B
(zh)
|
2016-03-07 |
2024-05-11 |
美商愛羅海德製藥公司 |
治療性化合物之標靶性配體
|
|
WO2017178656A1
(en)
|
2016-04-14 |
2017-10-19 |
Roche Innovation Center Copenhagen A/S |
TRITYL-MONO-GalNAc COMPOUNDS AND THEIR USE
|
|
SG10201913477UA
(en)
|
2016-04-29 |
2020-02-27 |
Univ Nanyang Tech |
G-quadruplex-containing antisense oligonucleotides
|
|
KR102520362B1
(ko)
|
2016-06-30 |
2023-04-10 |
쿄와 기린 가부시키가이샤 |
당쇄 리간드가 링커를 통해 올리고뉴클레오티드와 결합한 핵산 복합체
|
|
US11253601B2
(en)
|
2016-07-11 |
2022-02-22 |
Translate Bio Ma, Inc. |
Nucleic acid conjugates and uses thereof
|
|
WO2018013999A1
(en)
*
|
2016-07-15 |
2018-01-18 |
Am Chemicals Llc |
Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis
|
|
KR102403408B1
(ko)
|
2016-09-02 |
2022-05-30 |
애로우헤드 파마슈티컬스 인코포레이티드 |
표적화 리간드
|
|
WO2018067900A1
(en)
*
|
2016-10-06 |
2018-04-12 |
Ionis Pharmaceuticals, Inc. |
Method of conjugating oligomeric compounds
|
|
US11963974B2
(en)
|
2017-03-10 |
2024-04-23 |
National Center For Child Health And Development |
Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type Ia
|
|
SG11201908771YA
(en)
*
|
2017-03-22 |
2019-10-30 |
Univ California |
Modified oligonucleotides and therapeutic uses thereof
|
|
IL321221A
(en)
|
2017-04-05 |
2025-07-01 |
Silence Therapeutics Gmbh |
Products and compositions
|
|
CN110603330B
(zh)
|
2017-04-28 |
2023-09-05 |
协和麒麟株式会社 |
寡核苷酸衍生物或其盐
|
|
WO2019027009A1
(ja)
*
|
2017-08-02 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸複合体
|
|
TW201909925A
(zh)
*
|
2017-08-02 |
2019-03-16 |
日商協和醱酵麒麟有限公司 |
核酸複合體
|
|
CA3075598A1
(en)
*
|
2017-09-14 |
2019-03-21 |
Janssen Biopharma, Inc. |
Galnac derivatives
|
|
JP7365052B2
(ja)
*
|
2017-12-01 |
2023-10-19 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用
|
|
WO2019105403A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
WO2019105404A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US11492620B2
(en)
*
|
2017-12-01 |
2022-11-08 |
Suzhou Ribo Life Science Co., Ltd. |
Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof
|
|
WO2019105437A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US11414665B2
(en)
|
2017-12-01 |
2022-08-16 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof
|
|
JP7261494B2
(ja)
|
2017-12-01 |
2023-04-20 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用
|
|
WO2019128611A1
(en)
|
2017-12-29 |
2019-07-04 |
Suzhou Ribo Life Science Co., Ltd. |
Conjugates and preparation and use thereof
|
|
WO2019140102A1
(en)
|
2018-01-10 |
2019-07-18 |
Translate Bio Ma, Inc. |
Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
|
|
US11958878B2
(en)
*
|
2018-03-09 |
2024-04-16 |
Daiichi Sankyo Company, Limited |
Therapeutic agent for glycogen storage disease type IA
|
|
US20210155926A1
(en)
*
|
2018-04-05 |
2021-05-27 |
Silence Therapeutics Gmbh |
siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDS
|
|
BR112020022546A8
(pt)
|
2018-05-07 |
2022-05-17 |
Alnylam Pharmaceuticals Inc |
Entrega extra-hepática
|
|
CN111655849B
(zh)
*
|
2018-08-21 |
2024-05-10 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的药物组合物和缀合物及其用途
|
|
JP7376952B2
(ja)
*
|
2018-09-30 |
2023-11-09 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
ｓｉＲＮＡ複合体及びその調製方法と使用
|
|
GB2579253A
(en)
*
|
2018-11-28 |
2020-06-17 |
Pedanius Therapeutics Ltd |
Antibacterial antisense agents
|
|
AU2019390097A1
(en)
|
2018-11-30 |
2021-07-15 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
WO2020135673A1
(zh)
|
2018-12-28 |
2020-07-02 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
GB201821269D0
(en)
|
2018-12-28 |
2019-02-13 |
Nippon Shinyaku Co Ltd |
Myostatin signal inhibitor
|
|
CN111377985B
(zh)
*
|
2018-12-29 |
2023-11-10 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN111377984B
(zh)
*
|
2018-12-29 |
2024-03-05 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
WO2020147847A1
(zh)
*
|
2019-01-18 |
2020-07-23 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
AU2020280439B2
(en)
|
2019-05-22 |
2025-08-14 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
CN113614230B
(zh)
*
|
2019-05-22 |
2024-04-09 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN113227376B
(zh)
*
|
2019-05-22 |
2024-04-09 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
US20240200060A1
(en)
*
|
2019-05-22 |
2024-06-20 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
CN111973618B
(zh)
*
|
2019-05-23 |
2024-02-02 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与siRNA缀合物及制备方法和用途
|
|
CN111973619B
(zh)
*
|
2019-05-23 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
US20220315929A1
(en)
|
2019-05-24 |
2022-10-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
|
|
CN113795582B
(zh)
|
2019-05-24 |
2024-05-24 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
EP3978029A4
(en)
*
|
2019-05-24 |
2023-07-19 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE, METHOD OF MANUFACTURE AND USE
|
|
CN112007040B
(zh)
*
|
2019-05-31 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
用于治疗乙型病毒性肝炎的联合用药物
|
|
WO2021037205A1
(zh)
|
2019-08-29 |
2021-03-04 |
苏州瑞博生物技术股份有限公司 |
化合物和药物缀合物及其制备方法和用途
|
|
BR112022004461A2
(pt)
|
2019-09-10 |
2022-07-19 |
Daiichi Sankyo Co Ltd |
Conjugado de galnac-oligonucleotídeo para entrega ao fígado e método de fabricação do mesmo
|
|
EP4446336A3
(en)
|
2019-09-23 |
2025-06-25 |
Koranex Capital |
Neoglycoconjugates as vaccines and therapeutic tools
|
|
CA3160329A1
(en)
*
|
2019-11-06 |
2021-05-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
CA3161669A1
(en)
*
|
2019-11-26 |
2021-06-03 |
Dtx Pharma, Inc. |
Compound comprising a nucleic acid and methods
|
|
CN112876534B
(zh)
*
|
2019-11-29 |
2024-02-09 |
苏州瑞博生物技术股份有限公司 |
肝靶向化合物及缀合物
|
|
WO2021153047A1
(ja)
*
|
2020-01-29 |
2021-08-05 |
住友化学株式会社 |
核酸オリゴマーの製造方法
|
|
CN111269279B
(zh)
*
|
2020-02-24 |
2022-08-05 |
陕西师范大学 |
一种在温和条件下制备卤代糖的方法
|
|
MX2022011805A
(es)
|
2020-03-24 |
2023-01-11 |
Generation Bio Co |
Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con factor ix.
|
|
CA3172591A1
(en)
|
2020-03-24 |
2021-09-30 |
Douglas Anthony KERR |
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
|
|
CN113683651A
(zh)
*
|
2020-05-19 |
2021-11-23 |
上海京新生物医药有限公司 |
一种GalNAc中间体的制备方法
|
|
IL298406A
(en)
|
2020-05-22 |
2023-01-01 |
Wave Life Sciences Ltd |
Double stranded oligonucleotide compositions and methods relating thereto
|
|
US20230235330A1
(en)
|
2020-06-10 |
2023-07-27 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Conjugate of double-stranded sirna analogue
|
|
WO2022140702A1
(en)
|
2020-12-23 |
2022-06-30 |
Flagship Pioneering, Inc. |
Compositions of modified trems and uses thereof
|
|
CN116669746B
(zh)
|
2020-12-29 |
2025-09-09 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
CN117881786A
(zh)
|
2021-04-27 |
2024-04-12 |
世代生物公司 |
表达治疗性抗体的非病毒dna载体及其用途
|
|
EP4329884A1
(en)
|
2021-04-27 |
2024-03-06 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
WO2022246195A1
(en)
*
|
2021-05-20 |
2022-11-24 |
Olix Us, Inc. |
Functional moieties and their uses and synthetic preparation
|
|
CN115572241B
(zh)
*
|
2021-06-21 |
2024-08-30 |
润佳（苏州）医药科技有限公司 |
双价化合物、偶联物及其用途
|
|
WO2023282344A1
(ja)
|
2021-07-08 |
2023-01-12 |
日本新薬株式会社 |
腎毒性軽減剤
|
|
US20240285770A1
(en)
|
2021-07-08 |
2024-08-29 |
Nippon Shinyaku Co., Ltd. |
Precipitation suppressing agent
|
|
TW202337473A
(zh)
|
2021-07-08 |
2023-10-01 |
日商日本新藥股份有限公司 |
腎毒性減輕劑
|
|
US20240325428A1
(en)
|
2021-07-16 |
2024-10-03 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate containing same, and preparation method and use
|
|
EP4372086A1
(en)
|
2021-07-16 |
2024-05-22 |
Suzhou Ribo Life Science Co., Ltd. |
Double-stranded oligonucleotide, composition and conjugate containing double-stranded oligonucleotide, and preparation methods and uses
|
|
IL310547A
(en)
|
2021-08-05 |
2024-03-01 |
Sanegene Bio Usa Inc |
Alkyl substituted ribose derivatives in the '1 position and methods of use
|
|
KR20240082361A
(ko)
|
2021-09-22 |
2024-06-10 |
사네진 바이오 유에스에이 인크. |
올리고뉴클레오티드의 생체내 전달에 사용하기 위한 2'-알킬 또는 3'-알킬 변형된 리보스 유도체
|
|
CN118076621A
(zh)
|
2021-10-05 |
2024-05-24 |
美国圣因生物股份有限公司 |
多羟基化的环戊烷衍生物及使用方法
|
|
WO2023097251A1
(en)
*
|
2021-11-23 |
2023-06-01 |
Yale University |
Oligonucleotide-containing transcription factor targeting chimeras
|
|
CN118922431A
(zh)
|
2022-02-22 |
2024-11-08 |
美国圣因生物股份有限公司 |
5’-修饰的碳环核糖核苷酸衍生物及使用方法
|
|
WO2023171804A1
(ja)
|
2022-03-10 |
2023-09-14 |
日本新薬株式会社 |
抗ウイルスアンチセンスオリゴマー
|
|
JP2025509607A
(ja)
|
2022-03-14 |
2025-04-11 |
ジェネレーション バイオ カンパニー |
異種プライムブーストワクチン組成物及び使用の方法
|
|
KR20240161967A
(ko)
|
2022-03-16 |
2024-11-13 |
다이이찌 산쿄 가부시키가이샤 |
트랜스페린 수용체 2 의 발현을 억제하는 siRNA
|
|
EP4495241A1
(en)
|
2022-03-16 |
2025-01-22 |
Daiichi Sankyo Company, Limited |
Chemically-modified oligonucleotide having rnai activity
|
|
WO2023207615A1
(zh)
*
|
2022-04-26 |
2023-11-02 |
南京明德新药研发有限公司 |
一类含由天然核苷酸组成突出端的双链RNAi化合物
|
|
WO2023212134A2
(en)
*
|
2022-04-28 |
2023-11-02 |
Dicerna Pharmaceuticals, Inc. |
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid
|
|
WO2023220744A2
(en)
|
2022-05-13 |
2023-11-16 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
US20250179492A1
(en)
|
2022-06-22 |
2025-06-05 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
WO2024001172A1
(en)
*
|
2022-06-27 |
2024-01-04 |
Ractigen Therapeutics |
Oligonucleotide modulators activating complement factor h expression
|
|
WO2024006999A2
(en)
|
2022-06-30 |
2024-01-04 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
US20240218363A1
(en)
|
2022-07-11 |
2024-07-04 |
Sanegene Bio Usa Inc. |
Optimized 2'- modified ribose derivatives and methods of use
|
|
US20240052348A1
(en)
|
2022-08-05 |
2024-02-15 |
Sanegene Bio Usa Inc. |
Double stranded rna targeting angiotensinogen (agt) and methods of use thereof
|
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
|
WO2024081954A2
(en)
|
2022-10-14 |
2024-04-18 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting c3 and uses thereof
|
|
EP4628583A1
(en)
|
2022-12-02 |
2025-10-08 |
Shanghai Argo Biopharmaceutical Co., Ltd. |
Bicyclic abasic nucleic acid analogs and oligomeric compounds prepared therefrom
|
|
CN120569477A
(zh)
|
2022-12-19 |
2025-08-29 |
美国圣因生物股份有限公司 |
靶向cfb的小干扰rna及其用途
|
|
CN116178458A
(zh)
*
|
2022-12-26 |
2023-05-30 |
成都药明康德新药开发有限公司 |
一种糖苷化合物的合成
|
|
WO2024160204A1
(en)
*
|
2023-01-30 |
2024-08-08 |
Primelink Biotherapeutics (Suzhou) Co., Ltd. |
Polymer-oligonucleotide conjugates
|
|
US20240309383A1
(en)
|
2023-02-24 |
2024-09-19 |
Suzhou Sanegene Bio Inc. |
Small interfering rna targeting hbv and uses thereof
|
|
WO2024186673A2
(en)
|
2023-03-03 |
2024-09-12 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting apoc3 and uses thereof
|
|
WO2024188174A1
(zh)
|
2023-03-10 |
2024-09-19 |
苏州瑞博生物技术股份有限公司 |
一种药物组合物及其用途
|
|
WO2024238385A2
(en)
|
2023-05-12 |
2024-11-21 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
CN119061009A
(zh)
|
2023-06-01 |
2024-12-03 |
广东东阳光药业股份有限公司 |
一种新型的双链siRNA、其缀合物及其用途
|
|
WO2024263915A2
(en)
|
2023-06-21 |
2024-12-26 |
Sanegene Bio Usa Inc. |
Double stranded rna targeting proprotein convertase subtilisin kexin 9 (pcsk9) and methods of use thereof
|
|
CN119219716A
(zh)
*
|
2023-06-30 |
2024-12-31 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025016441A1
(zh)
*
|
2023-07-19 |
2025-01-23 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
AU2024301344A1
(en)
|
2023-07-24 |
2026-01-29 |
Sanegene Bio Usa Inc. |
Lipid-based enhancement agent for rna delivery and therapy
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
CN117384226B
(zh)
*
|
2023-09-14 |
2025-12-26 |
苏州盛诺维生物科技有限公司 |
一种GalNAc类化合物的合成工艺
|
|
AU2024369609A1
(en)
|
2023-10-31 |
2025-12-11 |
Korro Bio, Inc. |
Oligonucleotides comprising phosphoramidate internucleotide linkages
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025140299A1
(zh)
*
|
2023-12-26 |
2025-07-03 |
广东东阳光药业股份有限公司 |
一种新型的化合物及其用途
|
|
WO2025155911A1
(en)
|
2024-01-18 |
2025-07-24 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of hurler syndrome
|
|
WO2025207934A1
(en)
|
2024-03-28 |
2025-10-02 |
Lycia Therapeutics, Inc. |
Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies
|
|
WO2025228441A2
(en)
|
2024-04-30 |
2025-11-06 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting inhbe and uses thereof
|
|
CN118146284B
(zh)
*
|
2024-05-08 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
一种GalNAc化合物、其与寡核苷酸缀合物及制备方法
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2026017140A2
(en)
|
2024-07-18 |
2026-01-22 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting fxi and uses thereof
|